Ketogenic diet, amino acid metabolism, and seizure control.
The ketogenic diet has been utilized for many years as an adjunctive therapy in the management of epilepsy, especially in those children for whom antiepileptic drugs have not permitted complete relief. The biochemical basis of the dietary effect is unclear. One possibility is that the diet leads to alterations in the metabolism of brain amino acids, most importantly glutamic acid, the major excitatory neurotransmitter. In this review, we explore the theme. We present evidence that ketosis can lead to the following: 1) a diminution in the rate of glutamate transamination to aspartate that occurs because of reduced availability of oxaloacetate, the ketoacid precursor to aspartate; 2) enhanced conversion of glutamate to GABA; and 3) increased uptake of neutral amino acids into the brain. Transport of these compounds involves an uptake system that exchanges the neutral amino acid for glutamine. The result is increased release from the brain of glutamate, particularly glutamate that had been resident in the synaptic space, in the form of glutamine. These putative adaptations of amino acid metabolism occur as the system evolves from a glucose-based fuel economy to one that utilizes ketone bodies as metabolic substrates. We consider mechanisms by which such changes might lead to the antiepileptic effect.
Yudkoff
M
M
Division of Child Development and Rehabilitation, Children's Hospital of Philadelphia, 34th St. and Civic Center Blvd., Philadelphia, PA 19104, USA. yudkoff@email.chop.edu
Daikhin
Y
Y
Nissim
I
I
Lazarow
A
A
Nissim
I
I
D000596:Amino Acids / Q000378:metabolism*; D000818:Animals; D001921:Brain / Q000166:cytology / Q000378:metabolism*; D004734:Energy Metabolism / Q000502:physiology*; D004827:Epilepsy / Q000378:metabolism* / Q000503:physiopathology / Q000628:therapy*; D005526:Food, Formulated; D006801:Humans; D007657:Ketone Bodies / Q000096:biosynthesis*; D009435:Synaptic Transmission / Q000235:genetics
D000596:Amino Acids; D007657:Ketone Bodies